Reflections on the EULAR recommendations for the treatment of systemic sclerosis
Crossref DOI link: https://doi.org/10.1038/nrrheum.2016.212
Published Online: 2017-01-05
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pope, Janet E.
Text and Data Mining valid from 2017-01-05
Article History
First Online: 5 January 2017
Competing interests
: J.E.P. acts as a consultant for Actelion, Bayer, Biogen, BMS, Merck, Roche, Pfizer. She has received funding for clinical trials from Actelion, Bayer, BMS, Roche.